市場調査レポート

商品コード

1800841

ゲノミクスの市場レポート：コンポーネント別、用途別、技術別、エンドユーザー別、地域別、2025～2033年

Genomics Market Report by Component, Application, Technology, End-User, and Region 2025-2033

出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 447,600円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペースト、印刷はできません。

PDF & Excel (5 User License)

USD 3,999 596,850円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストはできませんが、印刷は5部まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 746,100円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストは可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.25円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のゲノミクスの市場規模は2024年に384億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに1,133億米ドルに達し、2025～2033年の間に12.77%の成長率（CAGR）を示すと予測しています。市場の主な促進要因は、遺伝子異常を検出するためにがんなどの慢性疾患で次世代シーケンサー（NGS）の使用が増加していること、ゲノムシーケンスが必要な遺伝性疾患やウイルス性疾患の有病率が上昇していることです。さらに、ゲノミクス分野における最先端技術の導入は、応用と研究を強化しています。さらに、個別化医療の普及によって患者の転帰は改善されつつあり、ゲノム情報に基づいてカスタマイズされた治療レジメンへの需要が高まっています。

ゲノミクス市場の分析

主な市場促進要因：2025年のゲノミクス市場規模は、遺伝子配列決定技術の進歩と個別化医療への関心の高まりによって成長を遂げています。研究開発への投資は極めて重要であり、ゲノミクス市場価値を押し上げています。
主な市場動向：ゲノミクスにおける人工知能（AI）と機械学習（ML）の統合は、ゲノミクス市場の主要動向であり、ゲノミクス市場の研究能力を向上させます。この動向は予測モデリングの精度を高め、正確なゲノミクス市場予測につながります。CRISPR遺伝子編集技術の採用は、ゲノミクス市場の需要に直接影響を与える治療用途の大きな変化を浮き彫りにしています。
地理的動向：北米は高度なヘルスケアインフラを持ち、研究とイノベーションに重点を置いているため、ゲノミクス市場の収益において優位を占めています。アジア太平洋地域はゲノミクス市場の成長率が最も速く、政府のイニシアチブの増加やゲノミクス研究への注目の高まりがそれを後押ししています。この拡大により、ゲノミクス市場概要が多様化し、地域ごとに異なる成長展望が示されることになります。
競合情勢：ゲノミクス市場の主要企業には、Illumina, Inc.、Thermo Fisher Scientific、QIAGEN、Agilent Technologies、Oxford Nanopore Technologies、CRISPR Therapeuticsなどがあります。これらの企業はゲノミクス市場の展望を決定する上で極めて重要であり、その競争戦略とイノベーションは市場収益に大きく貢献しています。
課題と機会：遺伝子データに関連する倫理的懸念とゲノム配列決定に関連する高コストが、ゲノミクス市場における課題となっています。しかし、これらの課題は、ゲノミクス市場の需要増加に対応するための技術革新の機会も明らかにしています。費用対効果の高いシーケンス手法の開発や倫理的ガイドラインの確立は、市場の価値をさらに高め、ゲノミクス市場の成長を促進する可能性があります。

ゲノミクス市場の動向

シーケンス技術の技術革新

特に次世代シーケンシング（NGS）とCRISPR-Cas9ゲノム改変イノベーションにおける革新的な進歩の急速なペースは、ゲノミクス市場の重要な促進要因となっています。診断、個別化医療、研究など多様な用途にシーケンスサービスを提供する新興企業も登場しています。NGSのような高度な技術はゲノム解析を大幅に改善し、より迅速で正確、かつ経済的な解析を可能にしています。政府と産業界からの資金援助も、市場の成長には不可欠であり、研究努力と革新的技術の商業化を支援しています。消費者向け遺伝子検査で著名な23andMeや、遠隔医療遺伝相談を強化するために1,400万米ドルの資金を獲得したGenome Medicalのような例は、ゲノミクスとヘルスケアサービスの融合が進んでいることを裏付けています。これらの進歩は、ゲノミクスをより入手しやすく、使いやすくすることに貢献し、その結果、世界のゲノミクス市場規模は2025年に大きな成長を遂げると予想されます。

個別化医療への需要の高まり

市場のもう1つの重要な促進要因は、患者一人ひとりの特性に合わせて医療をカスタマイズする個別化医療に対する需要が世界中で高まっていることです。個別化医療は、遺伝子データに大きく依存し、個人の遺伝子構成に合わせた特定の治療法の開発に情報を提供することで、従来の一般的な医療から、より正確で効率的な治療へと移行します。これはまた、「ゲノミクス市場とは何か」という問いに対する答えを見つけるのに役立つ消費者の意識向上を促進します。これとともに、病気の遺伝的原因、遺伝性疾患の頻度の増加、さまざまな病気に対する従来の治療法の限界に対する認識と知識の拡大が、需要増加に拍車をかけています。個別化医療におけるゲノミクスの使用は、予防と正確な治療を優先することで、患者の結果を向上させ、費用対効果の高いヘルスケアアプローチを提供することを目的としており、ゲノミクスへの投資と研究を促進しています。

臨床応用と診断の拡大

ゲノミクス技術は、遺伝子疾患の特定、がんスクリーニング、感染症のモニタリングなど、臨床応用や診断への利用が拡大していることも、市場の成長を後押ししています。疾患の遺伝的基盤に対する理解が深まったことで、ゲノミクスを臨床治療に取り入れることが可能になり、その結果、特定の疾患に対する個人のリスクを予測し、治療の選択を導き、疾患の進行を追跡することができる新しい診断ツールや遺伝子検査が生み出されるようになりました。ゲノミクス技術の進歩は、リキッドバイオプシーやNIPTのような診断分野での可能性を広げ、ゲノミクスがヘルスケアや診断に革命を起こす重要な役割を担っていることを浮き彫りにし、この分野での需要を牽引し続けると予想されます。

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ

第11章 SWOT分析

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

第14章価格指標

第15章競合情勢

市場構造
主要企業
主要企業のプロファイル
- 23andMe, Inc.
- Agilent Technologies, Inc.
- Bayer Aktiengesellschaft
- BGI Genomics Co. Ltd.
- Bio-RAD Laboratories Inc.
- Danaher Corporation
- Illumina Inc.
- Oxford Nanopore Technologies
- PerkinElmer Inc.
- Myriad Genetics Inc.
- Roche Holding AG
- Thermo Fisher Scientific Inc.

図表

List of Figures

Figure 1: Global: Genomics Market: Major Drivers and Challenges
Figure 2: Global: Genomics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Genomics Market: Breakup by Component (in %), 2024
Figure 4: Global: Genomics Market: Breakup by Application (in %), 2024
Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2024
Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2024
Figure 7: Global: Genomics Market: Breakup by Region (in %), 2024
Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: Global: Genomics (Products) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Genomics (Services) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: North America: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: North America: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: United States: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: United States: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Canada: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: China: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: China: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Japan: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: India: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: India: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: South Korea: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Australia: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Indonesia: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Others: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Others: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Europe: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Germany: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: France: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: France: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: United Kingdom: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Italy: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Spain: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Russia: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Others: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Others: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Latin America: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Brazil: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Mexico: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Others: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Others: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Global: Genomics Industry: SWOT Analysis
Figure 90: Global: Genomics Industry: Value Chain Analysis
Figure 91: Global: Genomics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Genomics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million USD), 2025-2033
Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million USD), 2025-2033
Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Genomics Market: Competitive Structure
Table 8: Global: Genomics Market: Key Players

Product Code: SR112025A2246

The global genomics market size reached USD 38.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 113.3 Billion by 2033, exhibiting a growth rate (CAGR) of 12.77% during 2025-2033. The market's main growth drivers are the increasing use of next-generation sequencing (NGS) in chronic diseases like cancer to detect genetic abnormalities and the rise in the prevalence of hereditary and viral disorders that require genomic sequencing. Additionally, the introduction of cutting-edge technologies in the genomics sector is enhancing applications and research. Furthermore, patient outcomes are being improved by the growing use of personalized medicine, which is driving the need for customized treatment regimens based on genomic information.

Genomics Market Analysis:

Major Market Drivers: The genomics market size 2025 is experiencing growth driven by advancements in genetic sequencing technologies and an increasing interest in personalized medicine. Investments in R&D are pivotal, pushing the genomics market value upwards.
Key Market Trends: Artificial intelligence (AI) and machine learning (ML) integration in genomics refer to the key genomics market trends, enhancing genomics market research capabilities. This trend aids in refining predictive modeling, leading to precise genomics market forecasts. The adoption of CRISPR gene editing technology highlights a significant shift in therapeutic applications, directly influencing genomics market demand.
Geographical Trends: North America dominates in terms of genomics market revenue, due to its advanced healthcare infrastructure and a strong focus on research and innovation. The Asia-Pacific region shows the fastest genomics market growth rate, propelled by increasing government initiatives and a burgeoning focus on genomics research. This expansion offers a diverse genomics market overview, signaling varied growth prospects across different regions.
Competitive Landscape: Notable market players in the genomics sector include Illumina, Inc., Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Oxford Nanopore Technologies, and CRISPR Therapeutics, among others. These entities are crucial in determining the genomics market outlook, with their competitive strategies and innovations significantly contributing to the market revenue.
Challenges and Opportunities: Ethical concerns related to genetic data and the high costs associated with genomic sequencing pose challenges in the genomics market. Yet, these challenges also unveil opportunities for innovation to meet the increasing genomics market demand. Developing cost-effective sequencing methods and establishing ethical guidelines could further bolster the genomics market value and facilitate genomics market growth.

Genomics Market Trends:

Technological innovations in sequencing technologies

According to the genomics market analysis, the fast pace of innovative advancements, especially in next-generation sequencing (NGS) and CRISPR-Cas9 genome altering innovations, serves as an essential driver for the genomics showcase. The emergence of startups providing sequencing services for diverse uses, such as diagnostics, personalized medicine, and research. Sophisticated technologies like NGS have greatly improved genomic analysis, ensuring it is quicker, more precise, and economical. Government and industry funding are also vital in growing the market, aiding research efforts and the commercialization of innovative technologies. Examples like 23andMe, a prominent player in consumer genetic testing, and Genome Medical, which recently obtained $14 million in funding to enhance its telehealth genetic consultations, underscore the growing fusion of genomics and healthcare services. These advancements contribute to making genomics more attainable and usable, thereby making the global genomics market size 2025 experience significant growth.

Growing demand for personalized medicine

Another important driver of the market is the rising across the globe need for personalized medicine, which customizes medical care according to each patient's unique characteristics. Customized medical treatment depends greatly on genetic data to inform the creation of specific therapies tailored to an individual's genetic composition, moving away from the generalized approach of traditional medicine to more accurate and efficient treatments. This also facilitates enhanced awareness among consumers that helps them find an answer for the "what is the genomics market?" question. Along with this, the increasing need is fueled by the expanding recognition and knowledge of the genetic causes of diseases, the increasing frequency of genetic conditions, and the limitations of conventional therapies for various illnesses. Using genomics in personalized medicine aims to enhance patient results and provides a cost-effective healthcare approach by prioritizing prevention and accurate treatment, which drives more investments and research in genomics.

Expansion in clinical applications and diagnostics

The market is also growing due to genomics technologies being utilized more for clinical applications and diagnostics, such as identifying genetic disorders, cancer screening, and monitoring infectious diseases. Improved understanding of the genetic basis of diseases has allowed for the incorporation of genomics into clinical care, resulting in the creation of novel diagnostic tools and genetic tests that can anticipate an individual's risk for specific conditions, guide treatment choices, and track disease advancement. A question arises, what is the demand for genomics, particularly in the field of clinical applications and diagnostics? Advancements in genomics technologies are anticipated to keep driving demand in this field, expanding their potential in diagnostics such as liquid biopsies and NIPT, highlighting the critical role genomics plays in revolutionizing healthcare and diagnostics.

Genomics Market Segmentation:

Breakup by Component:

Products
- Instruments and Software
- Consumables and Reagents
Services
- Core Genomics Services
- NGS-Based Services
- Biomarker Translation Services
- Computational Services
- Others

Consumables and reagents account for the majority of the market share

The consumables and reagents sector dominates the market due to their essential role in a variety of genomic procedures including DNA sequencing, gene editing, and sample preparation. With the increased use of genomics in sectors such as healthcare, agriculture, and biotechnology, there is a rising need for specific consumables and reagents, leading manufacturers to enhance and extend their product range. This is promoting the development of the consumables industry, emphasizing its crucial role in driving and applying genomics technologies, making a substantial contribution to the market's overall growth. Moreover, the strong demand for these products, which are essential for ensuring the accuracy and reliability of genomic analyses in research and clinical diagnostics, further solidifies the dominance of this industry sector.

Breakup by Application:

Functional Genomics
Epigenomics
Biomarkers Discovery
Pathway Analysis
Others

Functional genomics holds the largest share of the industry

Functional genomics, which focuses on gene functions and interactions, has become the dominant area in the market, showcasing its crucial importance in comprehending intricate biological processes and disease mechanisms. Utilizing high-throughput technologies including RNA sequencing and CRISPR-Cas9 in functional genomics enables in-depth study of gene expression and regulation, leading to progress in biomedical research and healthcare. Moreover, the growing emphasis on exploring the functional characteristics of the genome, along with the quick advancements in technology, positions functional genomics as a major force driving growth and innovation in the overall market.

Breakup by Technology:

Sequencing
Microarray
Polymerase Chain Reaction
Nucleic Acid Extraction and Purification
Others

Sequencing represents the leading market segment

Sequencing technology is the main component of the market due to its crucial role in deciphering the genetic information found in DNA and RNA, making it the largest technological segment. The critical insights provided by sequencing drive this prominence in personalized medicine, genetic research, and diagnostic applications by uncovering genetic variations and mutations. Furthermore, the rise of NGS technologies is changing this field by offering unparalleled speed, accuracy, and cost-efficiency compared to traditional techniques. NGS enables a detailed analysis of genomes, exomes, and transcriptomes, allowing for progress in comprehending complex diseases, evolutionary biology, and microbial genomics.

Breakup by End-User:

Research Centers
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others

Pharmaceutical and biotechnology companies exhibit a clear dominance in the market

Pharmaceutical and biotechnology companies are playing a major role in the market, emphasizing their significance in driving drug development and personalized medicine forward. These areas apply genomic data to identify novel targets for drugs, understand the genetic origins of diseases, and develop tailored treatments using individuals' genetic data. For instance, Illumina Inc., a top company in DNA sequencing and array-based technologies worldwide, partnered with Nashville Biosciences, LLC, a prominent clinical and genomic data company that is a subsidiary of Vanderbilt University Medical Center (VUMC), to reveal the five original members of the Alliance for Genomic Discovery (AGD). The extended agreement aims to quicken the treatment development process by conducting thorough genomics research and establishing a high-quality clinical genomics database. AbbVie, Amgen, AstraZeneca, Bayer, and Merck will pool their resources to fund the sequencing of 250,000 samples and can use the data for developing drugs and improving therapies.

Breakup by Region:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America leads the market, accounting for the largest genomics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for genomics.

North America holds the largest market share due to its advanced healthcare system, significant investment in research and development, and the presence of top pharmaceutical and biotechnology companies. Additionally, the region's advanced technology in genomics and bioinformatics, along with these factors, is fostering a favorable environment for the development and advancement of the genomics field. North America's strong position in the global market is supported by the close collaboration between academic and research institutions with the industry, leading to innovation and setting trends that impact global genomics practices and policies.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the genomics industry include

23andMe, Inc
Agilent Technologies, Inc.
Bayer AG
BGI Group
Bio-Rad Laboratories, Inc.
Danaher Corporation
Illumina, Inc.
Oxford Nanopore Technologies
PerkinElmer, Inc.
Myriad Genetics, Inc.
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.

Major players in the industry are involved in various strategic activities to uphold and strengthen their market presence. These businesses are making significant investments in research and development to launch new genomic technologies, services, and solutions that cater to their customers' changing needs. Working together, forming partnerships, and making acquisitions are important strategies that enable them to enhance their technological capabilities, enter new markets, and gain new genomic applications and intellectual property. Additionally, these top companies are focusing on improving their bioinformatics systems to manage and analyze the large amounts of data generated from genomic sequencing. This enables full solutions that help translate genomic findings into progress in clinical and agricultural sectors.

Key Questions Answered in This Report

1.What is the genomics market?
2.How big is the genomics market?
3.What is the market forecast for genomics?
4.What are the key factors driving the global genomics market?
5.What has been the impact of COVID-19 on the global genomics market?
6.What is the breakup of the global genomics market based on the component?
7.What is the breakup of the global genomics market based on the application?
8.What is the breakup of the global genomics market based on the technology?
9.What is the breakup of the global genomics market based on the end-user?
10.What are the key regions in the global genomics market?
11.Who are the key players/companies in the global genomics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Genomics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Component

6.1 Products
- 6.1.1 Market Trends
- 6.1.2 Major Types
  - 6.1.2.1 Instruments and Software
  - 6.1.2.2 Consumables and Reagents
- 6.1.3 Market Forecast
6.2 Services
- 6.2.1 Market Trends
- 6.2.2 Major Types
  - 6.2.2.1 Core Genomics Services
  - 6.2.2.2 NGS-Based Services
  - 6.2.2.3 Biomarker Translation Services
  - 6.2.2.4 Computational Services
  - 6.2.2.5 Others
- 6.2.3 Market Forecast

7 Market Breakup by Application

7.1 Functional Genomics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Epigenomics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Biomarkers Discovery
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Pathway Analysis
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Technology

8.1 Sequencing
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Microarray
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Polymerase Chain Reaction
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Nucleic Acid Extraction and Purification
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by End-User

9.1 Research Centers
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Hospitals and Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Pharmaceutical and Biotechnology Companies
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 23andMe, Inc.
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
- 15.3.2 Agilent Technologies, Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Bayer Aktiengesellschaft
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 BGI Genomics Co. Ltd.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
- 15.3.5 Bio-RAD Laboratories Inc.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Danaher Corporation
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Illumina Inc.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Oxford Nanopore Technologies
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 PerkinElmer Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
- 15.3.10 Myriad Genetics Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
- 15.3.11 Roche Holding AG
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
- 15.3.12 Thermo Fisher Scientific Inc.
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
  - 15.3.12.4 SWOT Analysis

ゲノミクスの市場レポート：コンポーネント別、用途別、技術別、エンドユーザー別、地域別、2025～2033年

Genomics Market Report by Component, Application, Technology, End-User, and Region 2025-2033

ゲノミクス市場の分析

ゲノミクス市場の動向

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のゲノミクス市場

第6章 市場内訳：コンポーネント別

第7章 市場内訳：用途別

第8章 市場内訳：技術別

第9章 市場内訳：エンドユーザー別

第10章 市場内訳：地域別

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 価格指標

第15章 競合情勢